Effect of long-term salmeterol treatment on exercise-induced asthma

New England Journal of Medicine

Volumn 339, Issue 3, 1998, Pages 141-146

  Nelson, Jo Ann ^a   Strauss, Louise ^a   Skowronski, Mary ^a   Ciufo, Russell ^a   Novak, Ronald ^a   McFadden Jr , E R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALMETEROL; SALMETEROL XINAFOATE;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; TIME FACTORS;

EID: 0032537796     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199807163390301     Document Type: Article

References (25)

1. 2-agonist. BMJ 1990;301:1365-8.
2. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 1992;67:1014-7.
3. Sears MR, Taylor DR, Print CG, et al. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.
4. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;1:554-8.
5. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-203.
6. 2-agonists in asthma. N Engl J Med 1992;327:1204-8.
7. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-7.
8. Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-7.
9. 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol 1995;95:641-51.
10. Gilbert IA, Fouke JM, McFadden ER Jr. Intra-airway thermodynamics during exercise and hyperventilation in asthmatics. J Appl Physiol 1988;64: 2167-74.
11. McFadden ER Jr, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma: new insights into pathophysiology and possible pathogenesis. J Clin Invest 1986;78:18-25.
12. Standardization of spirometry - 1987 update: statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
13. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, N.J.: Prentice-Hall, 1984.
14. McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994;330:1362-7.
15. Repsher LH, Anderson JA, Bush RK, et al. Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Chest 1984;85:34-8.
16. Strauss RH, McFadden ER Jr, Ingram RH Jr, Jaeger JJ. Enhancement of exercise-induced asthma by cold air. N Engl J Med 1977;297:743-7.
17. Pearlman DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
18. Hetzel MR, Batten JC, Clark TJH. Do sympathomimetic amines present exercise-induced asthma by bronchodilatation alone? Br J Dis Chest 1977;71:109-14.
19. Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991;100: 1254-60.
20. Kemp JP, Dockhorn RJ, Busse WW, Bleecker ER, Van As A. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med 1994;150:1612-5.
21. Newnham DM, Ingram CG, Earnshaw J, Palmer JBD, Dhillon DP. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of patients with mild, stable asthma. Respir Med 1993;87:439-44.
22. Schoeffel RD, Anderson SD, Seale JP. The protective effect and duration of action of metaproterenol aerosol on exercise-induced asthma. Ann Allergy 1981;46:273-5.
23. Higgs CMB, Laszlo G. The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol. Br J Dis Chest 1983;77:262-9.
24. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8.
25. Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996; 153:65-9.